Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1695759

registered interest
date	13/03/2024
answering body	Department for Science, Innovation and Technology
answering dept id	216
answering dept short name	Science, Innovation and Technology
answering dept sort name	Science, Innovation and Technology
hansard heading	Advanced Therapy Medicinal Products: Scotland
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Science, Innovation and Technology, what steps her Department is taking to increase Scotland’s (a) manufacturing capacity for and (b) delivery of cell and gene therapies.
tabling member constituency	Edinburgh South
tabling member printed	Ian Murray
uin	18417
answer	answer is ministerial correction date of answer 21/03/2024 answer text <p>The government is investing significantly to support manufacturing and delivery of cell and gene therapies.</p><p /><p>Since 2021, government has launched three UK-wide capital grant schemes – up to £118 million of funds – to incentivise manufacturing investments, including in advanced therapies. Last year, government announced a further £520 million to increase investment in Life Sciences manufacturing.</p><p> </p><p>The UK is a world-leader in the development and manufacture of cell and gene therapies thanks to government investment in innovation and skills, including through the Cell and Gene Therapy Catapult which also coordinates the Advanced Therapy Treatment Centre network.</p><p> </p> answering member constituency Arundel and South Downs answering member printed Andrew Griffith question first answered 21/03/2024 09:26:38 answering member 4874 label Biography information for Andrew Griffith
tabling member	3966 label Biography information for Ian Murray

1656149

registered interest
date	01/09/2023
answering body	Treasury
answering dept id	14
answering dept short name	Treasury
answering dept sort name	Treasury
hansard heading	Revenue and Customs: Staff
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Chancellor of the Exchequer, how many staff working on Research and Development tax relief schemes in HMRC have (a) prior experience in and (b) qualifications relevant to the technological sector.
tabling member constituency	Edinburgh South
tabling member printed	Ian Murray
uin	196155
answer	answer is ministerial correction date of answer 06/09/2023 answer text <p>HMRC does not expect staff working on Research and Development (R&amp;D tax relief schemes to be experts in the field of technology. That is not required because it is HMRC’s responsibility to ask questions to establish that the claimant understands and has correctly applied the definition of qualifying R&amp;D. HMRC are seeking to gather information to test against the requirements for eligibility.</p><p> </p><p>HMRC staff work with customers to understand the commercial context of their activities and whether they qualify for R&amp;D relief and as part of the checking process. Where HMRC deal with complex matters HMRC staff can seek technical support or specialist advice.</p> answering member constituency Louth and Horncastle answering member printed Victoria Atkins question first answered 06/09/2023 16:06:09 answering member 4399 label Biography information for Victoria Atkins
tabling member	3966 label Biography information for Ian Murray

1656150

registered interest
date	01/09/2023
answering body	Treasury
answering dept id	14
answering dept short name	Treasury
answering dept sort name	Treasury
hansard heading	Research and Development Expenditure Credit
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Chancellor of the Exchequer, what recent assessment he has made of the potential impact of HMRC's Research and Development Tax relief reform changes on the number of UK SMEs submitting applications for tax relief.
tabling member constituency	Edinburgh South
tabling member printed	Ian Murray
uin	196156
answer	answer is ministerial correction date of answer 11/09/2023 answer text The Government is currently undertaking a review of R&amp;D tax reliefs, to ensure the UK remains a competitive location for cutting edge research, that the reliefs continue to be fit for purpose, and that taxpayer money is effectively targeted. A number of reforms have already been announced as part of this review.<p> </p>HMRC has considered the impacts of these measures, and these are set out Tax Information and Impact Notes published alongside any announcements.<p> </p>HMRC publishes annual statistics on the number of R&amp;D tax relief claims received: <a href="https://www.gov.uk/government/statistics/corporate-tax-research-and-development-tax-credit" target="_blank">https://www.gov.uk/government/statistics/corporate-tax-research-and-development-tax-credit</a> answering member constituency Louth and Horncastle answering member printed Victoria Atkins question first answered 11/09/2023 13:31:04 answering member 4399 label Biography information for Victoria Atkins
tabling member	3966 label Biography information for Ian Murray

1642779

registered interest
date	07/06/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Clinical Trials
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to help increase patient access to clinical trials; and what recent discussions he has had with the devolved Administrations on best practice in this area.
tabling member constituency	Edinburgh South
tabling member printed	Ian Murray
uin	188438
answer	answer is ministerial correction date of answer 21/06/2023 answer text <p>The Department works together with other Government departments and devolved administrations to support research and access to clinical trials across the United Kingdom. Our long-term vision, set out in 'Saving and Improving Lives: The Future of UK Clinical Research Delivery' was developed in collaboration with the devolved administrations and is in line with similar initiatives in England and the devolved administrations.</p><p> </p><p>To gain a better understanding of how health-related data flows in the UK, Professor Cathie Sudlow has been commissioned to conduct a review.</p><p> </p><p>The National Institute for Health and Care Research (NIHR), funded by the Department of Health and Social Care, runs the Be Part of Research service in collaboration with all the devolved administrations. Be Part of Research makes it easier for the public to find and take part in health and care research. The NIHR is also striving to improve diversity in research by analysing the demographics of participants in randomized controlled trials. The findings show that the participants' diversity, age, and gender are representative of the general population.</p><p> </p><p>The NIHR is dedicated to enhancing and investing in the talent pool of researchers in clinical trials. It has implemented measures to address under-representation and improve diversity. These measures include encouraging applications from diverse groups through positive action statements and expanding nomination processes for research fellowships to address under-representation based on gender and ethnicity.</p> answering member constituency Colchester answering member printed Will Quince grouped question UIN 187934 187936 187939 question first answered 21/06/2023 14:40:07 answering member 4423 label Biography information for Will Quince
tabling member	3966 label Biography information for Ian Murray

1642780

registered interest
date	07/06/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Vaccination: Manufacturing Industries
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether his Department is taking steps to help encourage vaccine manufacturers to manufacture their vaccines in the UK; and if he will make an assessment of the potential impact of higher levels of UK-based vaccine production on Scotland.
tabling member constituency	Edinburgh South
tabling member printed	Ian Murray
uin	188439
answer	answer is ministerial correction date of answer 14/06/2023 answer text <p>Over £405 million has been invested through the Vaccine Taskforce to secure and scale up the United Kingdom’s vaccine manufacturing capabilities to ensure a robust response to COVID-19 and potential future health emergencies.</p><p> </p><p>To further improve the UK's resilience to future health emergencies, we have recently announced the £38 million Biomanufacturing Fund to incentivise investment in the biomanufacturing supply chain for vaccines and therapeutics. Together this funding will improve the UK’s resilience to future health emergencies.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 14/06/2023 15:41:16 answering member 4492 label Biography information for Maria Caulfield
tabling member	3966 label Biography information for Ian Murray

1642781

registered interest
date	07/06/2023
answering body	Department for Science, Innovation and Technology
answering dept id	216
answering dept short name	Science, Innovation and Technology
answering dept sort name	Science, Innovation and Technology
hansard heading	Life Sciences: Scotland
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Science, Innovation and Technology, what steps her Department is taking to support the life sciences sector in Scotland.
tabling member constituency	Edinburgh South
tabling member printed	Ian Murray
uin	188440
answer	answer is ministerial correction date of answer 16/06/2023 answer text <p>On 26 May we announced a raft of measures to support the life sciences sector across the UK. This includes a new Biomanufacturing Fund, open to companies across the UK, and measures to improve the underlying business environment such as through pro-innovation review of technologies (life sciences), which will give industry and investors the certainty they need to drive innovation, investment and growth. We will ensure the sector has the finance it needs to grow through our Life Sciences Investment Envoy, Dan Mahony, and the Long-term Investment For Technology and Science (LIFTS) initiative, bolstering investment in companies across the UK.</p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 16/06/2023 12:09:18 answering member 4020 label Biography information for George Freeman
tabling member	3966 label Biography information for Ian Murray

1642381

registered interest
date	06/06/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Clinical Trials: Scotland
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking with the Scottish Government to facilitate data sharing and improve access to clinical trials in Scotland.
tabling member constituency	Edinburgh South
tabling member printed	Ian Murray
uin	187934
answer	answer is ministerial correction date of answer 21/06/2023 answer text <p>The Department works together with other Government departments and devolved administrations to support research and access to clinical trials across the United Kingdom. Our long-term vision, set out in 'Saving and Improving Lives: The Future of UK Clinical Research Delivery' was developed in collaboration with the devolved administrations and is in line with similar initiatives in England and the devolved administrations.</p><p> </p><p>To gain a better understanding of how health-related data flows in the UK, Professor Cathie Sudlow has been commissioned to conduct a review.</p><p> </p><p>The National Institute for Health and Care Research (NIHR), funded by the Department of Health and Social Care, runs the Be Part of Research service in collaboration with all the devolved administrations. Be Part of Research makes it easier for the public to find and take part in health and care research. The NIHR is also striving to improve diversity in research by analysing the demographics of participants in randomized controlled trials. The findings show that the participants' diversity, age, and gender are representative of the general population.</p><p> </p><p>The NIHR is dedicated to enhancing and investing in the talent pool of researchers in clinical trials. It has implemented measures to address under-representation and improve diversity. These measures include encouraging applications from diverse groups through positive action statements and expanding nomination processes for research fellowships to address under-representation based on gender and ethnicity.</p> answering member constituency Colchester answering member printed Will Quince grouped question UIN 187936 187939 188438 question first answered 21/06/2023 14:40:07 answering member 4423 label Biography information for Will Quince
tabling member	3966 label Biography information for Ian Murray

1642382

registered interest
date	06/06/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Diseases
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what discussions he has had with the Scottish Government on a coordinated approach to pandemic preparedness.
tabling member constituency	Edinburgh South
tabling member printed	Ian Murray
uin	187935
answer	answer is ministerial correction date of answer 14/06/2023 answer text <p>Whilst no specific discussions have taken place between the Secretary of State and Scottish Government on pandemic preparedness, there is well-established UK-wide working on health security, public health protection and pandemic preparedness across all four United Kingdom nations.</p><p>The UK’s approach to pandemic preparedness reflects the fact that health policy is devolved and that emergency response and recovery is founded on a principle of subsidiarity. However, various mechanisms are in place to ensure effective coordination across all four UK nations, including devolved Government representation on the cross-Government Pandemic Diseases Capabilities Board (PDCB). PDCB ensures that critical capabilities for pandemic preparedness and response are maintained and developed across all sectors.</p><p>In addition, the approach to taken to clinical countermeasures, which is a key plank of our preparedness and response capability for a future pandemic, is conducted on a UK-wide basis. Representatives from the Devolved Governments and their agencies sit on the Clinical Countermeasures Board to ensure alignment in our approach to the procurement and stockpiling of countermeasures such as vaccines, medicines, and consumables.</p><p>More generally, the Common Framework for Public Health Protection and Health Security was agreed by the Four Nations in October 2021 to strengthen strategic collaboration on health security, including communicable diseases. Delivery of the work programme under the Common Framework is overseen by the UK Health Protection Committee, which was established by legislation and is, in turn, supported by a Four Nations Health Protection Oversight Group.</p><p>The UK Chief Medical Officer (CMO) group acts as an additional senior level body to ensure alignment and coordination in our approach to health security, including pandemic preparedness, and is accountable to all four UK CMOs.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 14/06/2023 16:18:05 answering member 4492 label Biography information for Maria Caulfield
tabling member	3966 label Biography information for Ian Murray

1642383

registered interest
date	06/06/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Clinical Trials
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department will take to increase the diversity of (a) participants and (b) researchers in clinical trials in the UK.
tabling member constituency	Edinburgh South
tabling member printed	Ian Murray
uin	187936
answer	answer is ministerial correction date of answer 21/06/2023 answer text <p>The Department works together with other Government departments and devolved administrations to support research and access to clinical trials across the United Kingdom. Our long-term vision, set out in 'Saving and Improving Lives: The Future of UK Clinical Research Delivery' was developed in collaboration with the devolved administrations and is in line with similar initiatives in England and the devolved administrations.</p><p> </p><p>To gain a better understanding of how health-related data flows in the UK, Professor Cathie Sudlow has been commissioned to conduct a review.</p><p> </p><p>The National Institute for Health and Care Research (NIHR), funded by the Department of Health and Social Care, runs the Be Part of Research service in collaboration with all the devolved administrations. Be Part of Research makes it easier for the public to find and take part in health and care research. The NIHR is also striving to improve diversity in research by analysing the demographics of participants in randomized controlled trials. The findings show that the participants' diversity, age, and gender are representative of the general population.</p><p> </p><p>The NIHR is dedicated to enhancing and investing in the talent pool of researchers in clinical trials. It has implemented measures to address under-representation and improve diversity. These measures include encouraging applications from diverse groups through positive action statements and expanding nomination processes for research fellowships to address under-representation based on gender and ethnicity.</p> answering member constituency Colchester answering member printed Will Quince grouped question UIN 187934 187939 188438 question first answered 21/06/2023 14:40:07 answering member 4423 label Biography information for Will Quince
tabling member	3966 label Biography information for Ian Murray

1642385

registered interest
date	06/06/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Vaccination: Manufacturing Industries
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to onshore vaccine manufacturing capability; and what assessment his Department has made of the UK’s preparedness for Disease X.
tabling member constituency	Edinburgh South
tabling member printed	Ian Murray
uin	187937
answer	answer is ministerial correction date of answer 14/06/2023 answer text <p>The United Kingdom’s Government is taking steps across the health family to ensure the UK is prepared for any future pandemic. We have established the Centre for Pandemic Preparedness within UK Health Security Agency which is working to ensure the UK’s future pandemic response is faster, more effective and more efficient to reduce the negative impacts of health threats to the UK.</p><p>On vaccines, over £405 million has been invested through the Vaccine Taskforce to secure and scale up the UK’s vaccine manufacturing capabilities to ensure a robust response to COVID-19 and potential future health emergencies.</p><p>The UK Government has also announced the £38 million Biomanufacturing Fund to incentivise investment in the biomanufacturing supply chain for vaccines and therapeutics and the Government and Moderna have entered into a long-term strategic partnership in December 2022. Together this funding will improve the UK’s resilience to future health emergencies.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 14/06/2023 16:03:19 answering member 4492 label Biography information for Maria Caulfield
tabling member	3966 label Biography information for Ian Murray